We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Gastrointestinal Advisory Committee To Discuss GSK’s Entereg
Gastrointestinal Advisory Committee To Discuss GSK’s Entereg
November 30, 2007
The FDA’s Gastrointestinal Drugs Advisory Committee will meet in January to discuss GlaxoSmithKline (GSK) and Adolor’s opioid receptor antagonist Entereg, which has been delayed due to safety concerns.